QCIG
HQL
Quad-Cities Investment Group’s abrdn Life Sciences Investors HQL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-10,144
| Closed | -$144K | – | 183 |
|
2023
Q4 | $144K | Hold |
10,144
| – | – | 0.09% | 165 |
|
2023
Q3 | $127K | Buy |
+10,144
| New | +$127K | 0.08% | 170 |
|
2023
Q2 | – | Sell |
-10,137
| Closed | -$141K | – | 182 |
|
2023
Q1 | $141K | Sell |
10,137
-540
| -5% | -$7.52K | 0.1% | 161 |
|
2022
Q4 | $152K | Buy |
10,677
+220
| +2% | +$3.13K | 0.11% | 163 |
|
2022
Q3 | $143K | Sell |
10,457
-431
| -4% | -$5.89K | 0.11% | 157 |
|
2022
Q2 | $155K | Buy |
10,888
+267
| +3% | +$3.8K | 0.12% | 162 |
|
2022
Q1 | $176K | Buy |
10,621
+33
| +0.3% | +$547 | 0.11% | 172 |
|
2021
Q4 | $204K | Buy |
10,588
+286
| +3% | +$5.51K | 0.13% | 173 |
|
2021
Q3 | $214K | Buy |
10,302
+56
| +0.5% | +$1.16K | 0.15% | 153 |
|
2021
Q2 | $220K | Sell |
10,246
-955
| -9% | -$20.5K | 0.15% | 156 |
|
2021
Q1 | $221K | Buy |
+11,201
| New | +$221K | 0.17% | 142 |
|
2020
Q4 | – | Sell |
-10,745
| Closed | -$189K | – | 170 |
|
2020
Q3 | $189K | Buy |
10,745
+2
| +0% | +$35 | 0.18% | 129 |
|
2020
Q2 | $193K | Buy |
10,743
+196
| +2% | +$3.52K | 0.2% | 132 |
|
2020
Q1 | $158K | Buy |
10,547
+319
| +3% | +$4.78K | 0.2% | 119 |
|
2019
Q4 | $179K | Buy |
10,228
+184
| +2% | +$3.22K | 0.17% | 146 |
|
2019
Q3 | $151K | Sell |
10,044
-867
| -8% | -$13K | 0.13% | 169 |
|
2019
Q2 | $185K | Buy |
10,911
+234
| +2% | +$3.97K | 0.16% | 139 |
|
2019
Q1 | $182K | Sell |
10,677
-64
| -0.6% | -$1.09K | 0.17% | 133 |
|
2018
Q4 | $162K | Buy |
10,741
+259
| +2% | +$3.91K | 0.17% | 129 |
|
2018
Q3 | $215K | Buy |
10,482
+223
| +2% | +$4.57K | 0.19% | 117 |
|
2018
Q2 | $193K | Sell |
10,259
-1,812
| -15% | -$34.1K | 0.18% | 126 |
|
2018
Q1 | $233K | Buy |
+12,071
| New | +$233K | 0.3% | 108 |
|